生物标志物 生物标志物
Manmohi D Dake1,2, Himank Kavathekar1, Ashwin V Venkataraman2,3,4
1Silver Matter, Pune, Maharashtra, India.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
一种新的深度学习方法使用MRI扫描来检测阿尔茨海默病的粉样蛋白病理,为PET扫描提供了更安全,更容易获得的替代方案. 这种方法旨在改善早期诊断和患者的治疗结果.
科学领域:
- 神经成像是一种神经成像.
- 人工智能在医学中的应用
- 生物标志物发现发现
背景情况:
- 传统的阿尔茨海默氏症 (AD) 病理检测方法昂贵,侵入性且难以获得.
- 早期识别AD生物标志物对于及时干预和改善患者结果至关重要.
- 开发了一种使用多模态核磁共振 (MRI) 的新,成本效益高,非侵入性方法,用于检测粉样蛋白病理,这是阿尔茨海默症的一个关键标志.
研究的目的:
- 开发和验证一种深度学习模型,用于使用MRI扫描检测粉样蛋白病理.
- 为现有的AD生物标志物检测方法提供更安全,更实惠和更容易获得的替代方案.
- 为了利用常规获得的MRI扫描来提高AD诊断的临床洞察力.
主要方法:
- 在来自阿尔茨海默病神经成像计划 (ADNI) 的1488个配对粉样蛋白PET和MRI扫描上训练了一种深度学习模型.
- T1加权和T2加权的MRI扫描作为输入来合成代表粉样蛋白病理的图像.
- 用验证数据集的灵敏度,特异性和准确度指标评估模型性能,将合成图像SUVR得分与地面真实性PET图像进行比较.
主要成果:
- 深度学习模型在检测粉样蛋白阳性时,获得了0.70的灵敏度,0.72的特异性和0.71的准确性.
- 合成图像显示与原始PET图像有很强的对齐,可比的SUVR得分表明了这一点.
- 该模型在识别粉样蛋白阳性方面表现出临床相关的准确性.
结论:
- 这项研究提出了一种更安全,更实惠,更容易获得的粉样蛋白检测方法的概念证明.
- 开发的技术利用标准的MRI扫描来提供非侵入性的洞察力,用于识别早期疾病修饰疗法的候选人.
- 模型的进一步改进正在进行中,但该方法具有改善早期AD检测和患者预后的巨大潜力.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516


